BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15461447)

  • 1. Assembly of major histocompatibility complex (MHC) class II transcription factors: association and promoter recognition of RFX proteins.
    Burd AL; Ingraham RH; Goldrick SE; Kroe RR; Crute JJ; Grygon CA
    Biochemistry; 2004 Oct; 43(40):12750-60. PubMed ID: 15461447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
    Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
    J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CREB and phospho-CREB interact with RFX5 and CIITA to regulate MHC class II genes.
    Lochamy J; Rogers EM; Boss JM
    Mol Immunol; 2007 Feb; 44(5):837-47. PubMed ID: 16730065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.
    Masternak K; Barras E; Zufferey M; Conrad B; Corthals G; Aebersold R; Sanchez JC; Hochstrasser DF; Mach B; Reith W
    Nat Genet; 1998 Nov; 20(3):273-7. PubMed ID: 9806546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orientation and positional mapping of the subunits of the multicomponent transcription factors RFX and X2BP to the major histocompatibility complex class II transcriptional enhancer.
    Westerheide SD; Boss JM
    Nucleic Acids Res; 1999 Apr; 27(7):1635-41. PubMed ID: 10075994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter.
    Zhu XS; Linhoff MW; Li G; Chin KC; Maity SN; Ting JP
    Mol Cell Biol; 2000 Aug; 20(16):6051-61. PubMed ID: 10913187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y.
    Villard J; Peretti M; Masternak K; Barras E; Caretti G; Mantovani R; Reith W
    Mol Cell Biol; 2000 May; 20(10):3364-76. PubMed ID: 10779326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers.
    Jabrane-Ferrat N; Nekrep N; Tosi G; Esserman LJ; Peterlin BM
    Mol Cell Biol; 2002 Aug; 22(15):5616-25. PubMed ID: 12101253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.
    Zika E; Greer SF; Zhu XS; Ting JP
    Mol Cell Biol; 2003 May; 23(9):3091-102. PubMed ID: 12697811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissection of functional NF-Y-RFX cooperative interactions on the MHC class II Ea promoter.
    Caretti G; Cocchiarella F; Sidoli C; Villard J; Peretti M; Reith W; Mantovani R
    J Mol Biol; 2000 Sep; 302(3):539-52. PubMed ID: 10986117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the RFX complex and the RFX5(L66A) mutant: implications for the regulation of MHC class II gene expression.
    Garvie CW; Stagno JR; Reid S; Singh A; Harrington E; Boss JM
    Biochemistry; 2007 Feb; 46(6):1597-611. PubMed ID: 17279624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.
    Masternak K; Reith W
    EMBO J; 2002 Mar; 21(6):1379-88. PubMed ID: 11889043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA binding domain of RFX5: interactions with X-box DNA and RFXANK.
    Chakraborty M; Sengupta A; Bhattacharya D; Banerjee S; Chakrabarti A
    Biochim Biophys Acta; 2010 Oct; 1804(10):2016-24. PubMed ID: 20637319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II.
    Wiszniewski W; Fondaneche MC; Louise-Plence P; Prochnicka-Chalufour A; Selz F; Picard C; Le Deist F; Eliaou JF; Fischer A; Lisowska-Grospierre B
    Immunogenetics; 2003 Feb; 54(11):747-55. PubMed ID: 12618906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assembly of functional regulatory complexes on MHC class II promoters in vivo.
    Fontes JD; Jabrane-Ferrat N; Peterlin BM
    J Mol Biol; 1997 Jul; 270(3):336-45. PubMed ID: 9237901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes.
    Villard J; Muhlethaler-Mottet A; Bontron S; Mach B; Reith W
    Int Immunol; 1999 Mar; 11(3):461-9. PubMed ID: 10221658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hierarchy of nuclear localization signals governs the import of the regulatory factor X complex subunits and MHC class II expression.
    Nagarajan UM; Long AB; Harreman MT; Corbett AH; Boss JM
    J Immunol; 2004 Jul; 173(1):410-9. PubMed ID: 15210800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations and interactions between bare lymphocyte syndrome factors.
    DeSandro AM; Nagarajan UM; Boss JM
    Mol Cell Biol; 2000 Sep; 20(17):6587-99. PubMed ID: 10938133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5.
    Scholl T; Mahanta SK; Strominger JL
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6330-4. PubMed ID: 9177217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research progress on regulation of class II MHC expression].
    Sun QH; Peng JP
    Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):25-9. PubMed ID: 15127593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.